The Leukemia and Lymphoma Society invites letters of intent for its translational research programme awards.
These support new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application with the aim of finding better treatment and cures for leukemia, lymphoma and myeloma. Proposals should be based on molecular, cellular or integrated systems findings and be conceptually innovative.
Applicants must hold an MD, PhD or equivalent degree and be appointed to a non-profit institution at the time the funding commences. They may be of any nationality and be based anywhere in the world.
Grants are worth up to USD 650,000 over three years.
Deadline: 20th October 2023.